Rockwell Medical Announces Regulatory Approval Of Triferic AVNU In South Korea
-Commercial launch expected in June/July 2022-
-Rockwell Medical has an exclusive license agreement with Jeil Pharmaceutical Co., Ltd., for the rights to Triferic® and Triferic® AVNU in South